In her presentation at the 48th ONS Congress, in San Antonio, Texas, Gayle Somerstein, RN, OCN, BSN, MPH, MBA, reviews common adult learning styles that can be tailored to each patient’s individualized...
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
In a multicenter, randomized, open-label, phase 3 trial, researchers set out to determine whether an advanced surgical therapy, isolated hepatic perfusion, could improve outcomes among previously untreated...
Hypercholesterolemia and diabetes have a minimal impact on major adverse cardiovascular events (MACE) risk in patients with prostate cancer (PCa) who are treated with androgen deprivation therapy (ADT),...
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
Researchers investigated the association and the potential sex differences between hypertension and blood pressure in early adulthood (ages 30-40 years) with late-life brain health.
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.
Researchers aimed to longitudinally examine both the variability of musculoskeletal pain among individuals with breast cancer and any potential predictors for pain during the first 18 months of aromatase...
